<DOC>
	<DOCNO>NCT02768155</DOCNO>
	<brief_summary>A study evaluate Amniotic Fluid compare Saline Placebo Injection treatment subject osteoarthritic ( OA ) knee pain</brief_summary>
	<brief_title>Evaluation Amniotic Fluid Product Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Subject 30 year old . 2 . Subject diagnosis osteoarthritis ( OA ) define Grade 1 3 Kellgren Lawrence grade scale . 3 . Subject willing able provide inform consent participate procedure followup evaluation necessary complete study . 1 . Subject active infection injection site . 2 . Subject rheumatoid arthritis , psoriatic arthritis , diagnose autoimmune disorder could cause knee pain . 3 . BMI great 45 kg/m2 4 . Subject receive intraarticular hyaluronic acid ( HA ) injection treatment OA target knee within 3 month prior screen . 5 . Subject receive steroid platelet rich plasma ( PRP ) injection treatment OA target knee within 3 month prior screen . 6 . Subject major surgery , arthroplasty arthroscopy target knee within 26 week treatment plan surgery target knee within 180 day treatment . 7 . Subject pregnant plan become pregnant within 180 day treatment . 8 . Subject use investigational drug , device biologic within 12 week prior treatment . 9 . Subject significant medical condition , opinion Investigator , would interfere protocol evaluation participation . 10 . Subject history immunosuppressive chemotherapy last 5 year 11 . Subject autoimmune disease know history Acquired Immunodeficiency Syndrome ( AIDS ) HIV 12 . Subject prior radiation site 13 . Subject currently take anticoagulant therapy ( exclude Plavix Aspirin ) 14 . Diagnosis gout past 6 month 15 . Subject diagnosis osteoarthritis</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>OA , Osteoarthritis , Knee</keyword>
</DOC>